All About Ovidrel

Ovidrel is a prefilled syringe that contains hCG. This recombinant human chorionic gonadotropin is the only approved for use drug of its group. Women who use this drug may find it easy to use due to its prefilled syringe formulation.

Ovidrel is created and made by highest standards and procedure in technology which is the human DNA. This formulation is the only one of its kind that is given underneath the skin. A number of types of hCG medicines are synthesized from expectant women’s urine and intended to be given into the muscle tissue.

Egg cell and follicular development problems in women are the indications for use of Ovidrel. This drug also aids releasing luteinizing hormone to women who underwent desensitization of the pituitary gland that is usually part of the treatment of Assisted Reproductive Technology (ART). This drug is also indicated to stimulate ovulation to women and women that are anovulatory patients. The standard dose for this drug is 250 ug and should be injected daily straight after the final dose of any follicle stimulating drugs.

Keep in mind that ovidrel is a powerful substance that will possibly lead to Ovarian Hyperstimulation Syndrome or OHSS. Women who are hypersensitive to hCG and related ingredients, have ovarian malfunction, have thyroid and adrenal problems, and are expectant and lactating should not use the medication.

Abdominal pain, nausea and vomitng, and pain and inflammation from the site of injection are a few of the most common side effects of the medication. Reports have been made concerning the use of the drug and the risk of multiple births related to it. No reports have been made regarding drug interactions with another drug but it could produce a false positive result in pregnancy tests.

Before therapy will start with any gonadotropin drugs such as ovidrel, it is significant to have a comprehensive assessment regarding gynecological and endocrine disorders. It must be included in the evaluation to rule out pregnancy. The male partner must also be assessed for fertility capability.

There have been reports of having multiple births that usually happen in 17 cases out of 55 deliveries when using Ovidrel. It is essential for the couple to be conscious of the duration of the whole therapy and the possibilities of the treatment to be not effective or successful. Watchful monitoring of the women’s condition is a need and indicators of ovulation should be watched out for in order for the therapy to be a success.

To discover more about ovidrel kindly check out our website!

Processing your request, Please wait....